BHVNBiohaven Ltd.

CSNew York Stock Exchange (XNYS)·USD

Identity

Security key: 12514
Ticker: BHVN
Type: CS — Common Stock
Exchange: New York Stock Exchange(XNYS)
Venue group: NYSE
Operating MIC: XNYS
Market: stocks
Locale: us
Currency: USD
Listed: 2022-09-23
Round lot: 100
Active: Yes
Last seen in a load: 2026-08-14 20:49
Vendor updated: 2026-08-13 06:09
Ticker root / suffix: BHVN

Detail

Enriched 2026-08-14 20:47

Market cap: $2,173,520,008.59
Shares outstanding (class): 150,560,990
Shares outstanding (weighted): 151,043,781
SIC: 2834 PHARMACEUTICAL PREPARATIONS
Employees: 274
Location: NEW HAVEN, CT
Homepage: https://www.biohaven.com
Description: Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder and others. Its pipeline products include: BHV-2000, BHV-7000, BHV-2100, BHV-8000, BHV-1310, BHV-1300, BHV-1400, BHV-1600, BHV-1530, and BHV-1500.

Market cap and share counts drift.

Funds holding this security

105 funds · 108 positions · $193.90M reported value, as of 2026-03-31

All holders →

Fund	Ticker	Position value	% of fund	Balance	Match
State Street(R) SPDR(R) S&P(R) Biotech ETF SPDR SERIES TRUST	XBI	$32.53M	0.44%	3,844,682 NS	TICKER
iShares Russell 2000 ETF iShares Trust	IWM	$24.16M	0.03%	2,855,427 NS	TICKER
Janus Henderson Global Life Sciences Fund JANUS INVESTMENT FUND	—	$18.78M	0.36%	2,220,238 NS	TICKER
Janus Henderson Triton Fund JANUS INVESTMENT FUND	—	$14.93M	0.29%	1,765,050 NS	TICKER
VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS	VXF	$10.74M	0.01%	1,269,141 NS	TICKER
T. Rowe Price Health Sciences Fund, Inc. T. ROWE PRICE HEALTH SCIENCES FUND, INC.	—	$10.39M	0.10%	1,228,554 NS	TICKER
SMALLCAP World Fund Inc SMALLCAP World Fund Inc	—	$9.88M	0.01%	1,168,175 NS	TICKER
Janus Henderson Venture Fund JANUS INVESTMENT FUND	—	$8.72M	0.28%	1,030,292 NS	TICKER
iShares Russell 2000 Growth ETF iShares Trust	IWO	$8.12M	0.07%	959,577 NS	TICKER
iShares Biotechnology ETF iShares Trust	IBB	$7.76M	0.10%	917,535 NS	TICKER
Simplify Health Care ETF Simplify Exchange Traded Funds	PINK	$7.68M	3.28%	908,165 NS	TICKER
abrdn Life Sciences Investors —	—	$6.53M	1.16%	771,452 NS	TICKER
VANGUARD STRATEGIC EQUITY FUND VANGUARD HORIZON FUNDS	—	$4.15M	0.04%	490,599 NS	TICKER
College Retirement Equities Fund - Total Global… College Retirement Equities Fund	—	$3.29M	0.00%	388,989 NS	TICKER
T. Rowe Price Integrated U.S. Small-Cap Growth … T. ROWE PRICE INTEGRATED EQUITY FUNDS, INC.	—	$2.72M	0.03%	321,120 NS	TICKER

How positions resolve to the securities master. FIGI_COMPOSITE is exact identifier equality — both sides got the FIGI from Bloomberg. TICKER is a narrow fallback used only where the master row carries no FIGI at all (2,389 rows do not, disproportionately Irish-domiciled US listings like LIN and ACN). Roughly 22% of all positions resolve to the master.

This match is a candidate, not a mapping. N-PORT tickers are filer-entered free text and collide with delisted and foreign symbols. Only 13% of positions carry a ticker at all. Good enough to ask which funds report holding a symbol; not good enough to build exposure reporting on. Prefer the ISIN-resolved link, which is marked FIGI_COMPOSITE.

Funds holding this security

Identifiers

master.security_identifier

TICKERBHVN
CIK0001935979
ISINVGG1110E1079
Resolved through OpenFIGI from a holdings ISIN, not supplied by the securities vendor.

Identifiers

Classification

classification.v_security_classification

Asset class: Equity
Sector: Health Care
Industry: Pharmaceuticals
Source: LLMunreviewed
Self-reported confidence: 0.95
Model: deepseek
Rationale: Biohaven is a pharmaceutical company developing treatments for neurological disorders, matching the SIC code for pharmaceutical preparations.

Classifications are unreviewed model output. All 5,771 assignments carry source = LLM and is_reviewed = false. Confidence is the model’s own estimate and is not calibrated — it clustered at 0.90–0.98 across the whole first pass, including rows that later proved wrong. Use it to order a review queue, not as a probability. Two share classes of one issuer can disagree.

Classification

Fund data

Not linked to a fund series.

Either this is not a fund, or it is one the SEC share-class snapshot cannot reach — commodity trusts and notes have no series ID at all.